| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 115524 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AD8" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "P&C" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 58038 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AE8" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Life & Health" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 56512 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AF8" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Life" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 37499 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AH8" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Health" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 19014 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AI8" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Asset Management" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 875 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AJ8" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Bank" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 99 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AK8" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Total" |
|---|
| business_unit | "France" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 30598 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AE19" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Europe" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 43005 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AF19" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Total" |
|---|
| business_unit | "AXA XL" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 19277 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AG19" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Asia, Africa & EME-LATAM" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 19925 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AH19" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Total" |
|---|
| business_unit | "AXA IM" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 875 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AI19" |
|---|
|
| label | "Gross Written Premiums & Other Revenues" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Transversal & Other" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 1844 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AJ19" |
|---|
|
| label | "IFRS17/9 New Business Value (NBV)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 2233 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AD10" |
|---|
|
| label | "IFRS17/9 New Business Value (NBV)" |
|---|
| business_line | "Life & Health" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 2233 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AF10" |
|---|
|
| label | "IFRS17/9 New Business Value (NBV)" |
|---|
| business_line | "Life" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 1747 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AH10" |
|---|
|
| label | "IFRS17/9 New Business Value (NBV)" |
|---|
| business_line | "Health" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 486 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AI10" |
|---|
|
| label | "IFRS17/9 New Business Value (NBV)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "France" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 695 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AE21" |
|---|
|
| label | "IFRS17/9 New Business Value (NBV)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Europe" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 578 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AF21" |
|---|
|
| label | "IFRS17/9 New Business Value (NBV)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Asia, Africa & EME-LATAM" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 959 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AH21" |
|---|
|
| label | "New Business Contractual Service Margin (NB CSM)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 2199 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AD11" |
|---|
|
| label | "New Business Contractual Service Margin (NB CSM)" |
|---|
| business_line | "Life & Health" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 2199 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AF11" |
|---|
|
| label | "New Business Contractual Service Margin (NB CSM)" |
|---|
| business_line | "Life" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 1822 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AH11" |
|---|
|
| label | "New Business Contractual Service Margin (NB CSM)" |
|---|
| business_line | "Health" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 377 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AI11" |
|---|
|
| label | "New Business Contractual Service Margin (NB CSM)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "France" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 431 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AE22" |
|---|
|
| label | "New Business Contractual Service Margin (NB CSM)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Europe" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 740 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AF22" |
|---|
|
| label | "New Business Contractual Service Margin (NB CSM)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Asia, Africa & EME-LATAM" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 1028 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AH22" |
|---|
|
| label | "Present Value of Expected Premiums (PVEP)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 49357 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AD14" |
|---|
|
| label | "Present Value of Expected Premiums (PVEP)" |
|---|
| business_line | "Life & Health" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 49357 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AF14" |
|---|
|
| label | "Present Value of Expected Premiums (PVEP)" |
|---|
| business_line | "Life" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 37103 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AH14" |
|---|
|
| label | "Present Value of Expected Premiums (PVEP)" |
|---|
| business_line | "Health" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 12254 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AI14" |
|---|
|
| label | "Present Value of Expected Premiums (PVEP)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "France" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 22858 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AE25" |
|---|
|
| label | "Present Value of Expected Premiums (PVEP)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Europe" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 12651 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AF25" |
|---|
|
| label | "Present Value of Expected Premiums (PVEP)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Asia, Africa & EME-LATAM" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 13847 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AH25" |
|---|
|
| label | "IFRS17/9 NBV Margin" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "ratio" |
|---|
| currency | null |
|---|
| scale | 1 |
|---|
| value | 0.045 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AD15" |
|---|
|
| label | "IFRS17/9 NBV Margin" |
|---|
| business_line | "Life & Health" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "ratio" |
|---|
| currency | null |
|---|
| scale | 1 |
|---|
| value | 0.045 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AF15" |
|---|
|
| label | "IFRS17/9 NBV Margin" |
|---|
| business_line | "Life" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "ratio" |
|---|
| currency | null |
|---|
| scale | 1 |
|---|
| value | 0.047 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AH15" |
|---|
|
| label | "IFRS17/9 NBV Margin" |
|---|
| business_line | "Health" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "ratio" |
|---|
| currency | null |
|---|
| scale | 1 |
|---|
| value | 0.04 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AI15" |
|---|
|
| label | "IFRS17/9 NBV Margin" |
|---|
| business_line | "Total" |
|---|
| business_unit | "France" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "ratio" |
|---|
| currency | null |
|---|
| scale | 1 |
|---|
| value | 0.03 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AE26" |
|---|
|
| label | "IFRS17/9 NBV Margin" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Europe" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "ratio" |
|---|
| currency | null |
|---|
| scale | 1 |
|---|
| value | 0.046 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AF26" |
|---|
|
| label | "IFRS17/9 NBV Margin" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Asia, Africa & EME-LATAM" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "ratio" |
|---|
| currency | null |
|---|
| scale | 1 |
|---|
| value | 0.069 |
|---|
| source | "financial_supplement" |
|---|
| note | "13. Activity indicators!AH26" |
|---|
|
| label | "Total Assets" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 635.5 |
|---|
| source | "financial_supplement" |
|---|
| note | "14. Balance Sheet!D24" |
|---|
|
| label | "Goodwill" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 17.8 |
|---|
| source | "financial_supplement" |
|---|
| note | "14. Balance Sheet!D8" |
|---|
|
| label | "Other intangible assets" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 4.4 |
|---|
| source | "financial_supplement" |
|---|
| note | "14. Balance Sheet!D9" |
|---|
|
| label | "Shareholders' Equity group share" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 47.2 |
|---|
| source | "financial_supplement" |
|---|
| note | "14. Balance Sheet!I8" |
|---|
|
| label | "Non-controlling Interests" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 2.4 |
|---|
| source | "financial_supplement" |
|---|
| note | "14. Balance Sheet!I9" |
|---|
|
| label | "Financing debt" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 15.8 |
|---|
| source | "financial_supplement" |
|---|
| note | "14. Balance Sheet!I11" |
|---|
|
| label | "Insurance contract liabilities" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 470.4 |
|---|
| source | "financial_supplement" |
|---|
| note | "14. Balance Sheet!I12" |
|---|
|
| label | "Present Value of Future Cash Flows" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 432.6 |
|---|
| source | "financial_supplement" |
|---|
| note | "14. Balance Sheet!I13" |
|---|
|
| label | "Risk Adjustment" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 3.1 |
|---|
| source | "financial_supplement" |
|---|
| note | "14. Balance Sheet!I15" |
|---|
|
| label | "Contractual Service Margin (closing, pre-tax)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 33253 |
|---|
| source | "financial_supplement" |
|---|
| note | "15.CSM Rollforward!I17" |
|---|
|
| label | "Contractual Service Margin (closing, post-tax)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 25864 |
|---|
| source | "financial_supplement" |
|---|
| note | "15.CSM Rollforward!I21" |
|---|
|
| label | "Retained Earnings" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 41.4 |
|---|
| source | "financial_supplement" |
|---|
| note | "18. Shareholders Equity!D33" |
|---|
|
| label | "Undated Subordinated Debt" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 4.6 |
|---|
| source | "financial_supplement" |
|---|
| note | "18. Shareholders Equity!D32" |
|---|
|
| label | "Other Comprehensive Income" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | -6.8 |
|---|
| source | "financial_supplement" |
|---|
| note | "18. Shareholders Equity!D28" |
|---|
|
| label | "Book Value per Share" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1 |
|---|
| value | 24 |
|---|
| source | "financial_supplement" |
|---|
| note | "18. Shareholders Equity!D37" |
|---|
|
| label | "Underlying Earnings Before Tax" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 11044 |
|---|
| source | "financial_supplement" |
|---|
| note | "2. UE by LOB and Net Income!F20" |
|---|
|
| label | "Underlying Earnings Group Share" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 8368 |
|---|
| source | "financial_supplement" |
|---|
| note | "2. UE by LOB and Net Income!F24" |
|---|
|
| label | "Subordinated Debt Charges (post-tax)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | -174 |
|---|
| source | "financial_supplement" |
|---|
| note | "2. UE by LOB and Net Income!F36" |
|---|
|
| label | "Underlying Earnings for EPS" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 8195 |
|---|
| source | "financial_supplement" |
|---|
| note | "2. UE by LOB and Net Income!F37" |
|---|
|
| label | "Underlying Earnings Group Share (FY24)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 8078 |
|---|
| source | "financial_supplement" |
|---|
| note | "2. UE by LOB and Net Income!D24" |
|---|
|
| label | "Net Income Group Share" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 9797 |
|---|
| source | "financial_supplement" |
|---|
| note | "2. UE by LOB and Net Income!F34" |
|---|
|
| label | "Combined Ratio" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "ratio" |
|---|
| currency | null |
|---|
| scale | 1 |
|---|
| value | 0.906 |
|---|
| source | "financial_supplement" |
|---|
| note | "2. UE by LOB and Net Income!K10" |
|---|
|
| label | "Shares Outstanding (period-end)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "count" |
|---|
| currency | null |
|---|
| scale | 1000000 |
|---|
| value | 2055.38 |
|---|
| source | "financial_supplement" |
|---|
| note | "4. Shares & UEPS!D14" |
|---|
|
| label | "Average Shares Outstanding" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "count" |
|---|
| currency | null |
|---|
| scale | 1000000 |
|---|
| value | 2124 |
|---|
| source | "financial_supplement" |
|---|
| note | "4. Shares & UEPS!G20" |
|---|
|
| label | "EPS" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1 |
|---|
| value | 4.53 |
|---|
| source | "financial_supplement" |
|---|
| note | "4. Shares & UEPS!G32" |
|---|
|
| label | "Underlying EPS" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1 |
|---|
| value | 3.86 |
|---|
| source | "financial_supplement" |
|---|
| note | "4. Shares & UEPS!G33" |
|---|
|
| label | "Net Income ROE" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "ratio" |
|---|
| currency | null |
|---|
| scale | 1 |
|---|
| value | 0.188 |
|---|
| source | "financial_supplement" |
|---|
| note | "19. ROE&Gearing!D7" |
|---|
|
| label | "Average Adjusted Shareholders' Equity" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 51.3 |
|---|
| source | "financial_supplement" |
|---|
| note | "19. ROE&Gearing!D9" |
|---|
|
| label | "Underlying ROE" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "ratio" |
|---|
| currency | null |
|---|
| scale | 1 |
|---|
| value | 0.16 |
|---|
| source | "financial_supplement" |
|---|
| note | "19. ROE&Gearing!D11" |
|---|
|
| label | "Debt Gearing" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "ratio" |
|---|
| currency | null |
|---|
| scale | 1 |
|---|
| value | 0.223 |
|---|
| source | "financial_supplement" |
|---|
| note | "19. ROE&Gearing!D34" |
|---|
|
| label | "Financing Debt (senior)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 3.2 |
|---|
| source | "financial_supplement" |
|---|
| note | "19. ROE&Gearing!D19" |
|---|
|
| label | "Dated Subordinated Debt" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 12.6 |
|---|
| source | "financial_supplement" |
|---|
| note | "19. ROE&Gearing!D22" |
|---|
|
| label | "Eligible Own Funds" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 56.37036554258047 |
|---|
| source | "financial_supplement" |
|---|
| note | "20. Information on Solvency II!J8" |
|---|
|
| label | "Solvency Capital Requirement" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 25.151489436767747 |
|---|
| source | "financial_supplement" |
|---|
| note | "20. Information on Solvency II!J9" |
|---|
|
| label | "Solvency II Ratio" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "ratio" |
|---|
| currency | null |
|---|
| scale | 1 |
|---|
| value | 2.241233692513468 |
|---|
| source | "financial_supplement" |
|---|
| note | "20. Information on Solvency II!J10" |
|---|
|
| label | "Holdings Underlying Earnings" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | -1180 |
|---|
| source | "financial_supplement" |
|---|
| note | "12. Holdings!I15" |
|---|
|
| label | "Closing Cash Balance at AXA SA" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 5.6 |
|---|
| source | "financial_supplement" |
|---|
| note | "12. Holdings!I29" |
|---|
|
| label | "Net cash remittance from subsidiaries" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 7.5 |
|---|
| source | "financial_supplement" |
|---|
| note | "12. Holdings!I19" |
|---|
|
| label | "Dividends" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 4.6 |
|---|
| source | "financial_supplement" |
|---|
| note | "12. Holdings!I23" |
|---|
|
| label | "Share buy-backs" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000000 |
|---|
| value | 4.7 |
|---|
| source | "financial_supplement" |
|---|
| note | "12. Holdings!I24" |
|---|
|
| label | "Insurance Revenues (P&C)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1000000 |
|---|
| value | 57656 |
|---|
| source | "financial_supplement" |
|---|
| note | "5. P&C UE by Sub LOB!F9" |
|---|
|
| label | "Current Accident Year Loss Ratio" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "ratio" |
|---|
| currency | null |
|---|
| scale | 1 |
|---|
| value | 0.669 |
|---|
| source | "financial_supplement" |
|---|
| note | "5. P&C UE by Sub LOB!F10" |
|---|
|
| label | "Prior Year Reserve Development Ratio" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "ratio" |
|---|
| currency | null |
|---|
| scale | 1 |
|---|
| value | -0.011 |
|---|
| source | "financial_supplement" |
|---|
| note | "5. P&C UE by Sub LOB!F14" |
|---|
|
| label | "Expense Ratio (P&C)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "ratio" |
|---|
| currency | null |
|---|
| scale | 1 |
|---|
| value | 0.248 |
|---|
| source | "financial_supplement" |
|---|
| note | "5. P&C UE by Sub LOB!F15" |
|---|
|
| label | "Share price (period-end)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1 |
|---|
| value | 38.6445 |
|---|
| source | "yahoo" |
|---|
| note | "CS.PA close 2025-12-31" |
|---|
|
| label | "Share price (period-average)" |
|---|
| business_line | "Total" |
|---|
| business_unit | "Group" |
|---|
| fiscal_year | 2025 |
|---|
| period | "FY" |
|---|
| measure | "monetary" |
|---|
| currency | "EUR" |
|---|
| scale | 1 |
|---|
| value | 36.7633 |
|---|
| source | "yahoo" |
|---|
| note | "CS.PA avg 2025-01-01..2025-12-31" |
|---|
|
